Hamza Hashmi

Dr. Hamza Hashmi is a hematologist-oncologist at Memorial Sloan Kettering Cancer Center who specializes in multiple myeloma and other plasma cell disorders, including MGUS, smoldering myeloma, and AL amyloidosis. He cares for patients with newly diagnosed and relapsed disease, and his expertise includes CAR T-cell therapy, bispecific antibodies, bone marrow transplantation, and chemotherapy. Dr. Hashmi's research focuses on developing novel immunotherapies for myeloma through clinical trials and on understanding how myeloma interacts with immunotherapy so that treatment resistance can be overcome. He also contributes real-world evidence on cellular therapy outcomes. He is an investigator on several MSK trials, including studies of maintenance therapy after CAR T and next-generation CAR T-cell products.